From OHC
February 10, 2022
FOR IMMEDIATE RELEASE
Contact: Joanie Manzo
Director, Marketing & Physician Services
513-751-2145 x20143
joan.manzo@usoncology.com
OHC advanced practice provider and lead cancer genetic specialist, Andrew “Andy” Guinigundo, MSN, RN, CNP, ANP-BC, was recently elected to the Board of Directors of the Advanced Practitioner Society for Hematology and Oncology (APSHO), a society for nurse practitioners, physician assistants, clinical nurse specialists, pharmacists, and advanced degree nurses. APSHO’s mission is to improve the quality of care for patients with cancer by supporting critical issues in educational, clinical, and professional development for advanced practitioners in hematology and oncology.
Andy, a resident of Hyde Park, OH, has been serving OHC patients for nearly 21 years and has been a member of APSHO since 2016, most recently serving as Chair of its Professional Development and Leadership Committee. He was instrumental in establishing OHC’s Genetic Risk Evaluation and Testing (GREAT) Program in 2017. The GREAT Program provides genetic counseling and testing for people who may be at risk for a hereditary cancer syndrome and is an important component of OHC’s quality cancer care and prevention services. It recently received an Association of Community Cancer Centers (ACCC)/Pfizer grant aimed at increasing genetic testing in breast cancer patients.
“At OHC, Andy’s passion for oncology and hematology is consistently evident,” said OHC medical oncologist and hematologist, Randy Drosick, MD, who also serves as the President of OHC. “It’s rewarding to see a member of our team helping to shape the landscape of healthcare and improve the quality of care for cancer patients.”
“When I first learned about the formation of APSHO, I wanted in!” said Andy. “It’s an advanced provider society designed by us and caters to our special skill set and needs. I hope to bring a perspective to the Board that is as unique as OHC, a private community practice with the backing of a major national network that is involved in cutting edge care, research, and genetics.”
OHC, the region’s leading experts in the treatment of nearly every form of adult cancer and complex blood disorders, has been fighting cancer on the front lines for more than 35 years. For more information on the expertise and compassion provided by OHC’s cancer specialists or to request a second opinion, call 1-888-649-4800 or visit ohcare.com.
OHC (Oncology Hematology Care) has been fighting cancer on the front lines for more than 35 years. We are the region’s leading experts in the treatment of nearly every form of adult cancer and complex blood disorder. OHC cancer experts include medical, hematology, radiation therapy, transplantation, cellular therapy, gynecologic, and breast surgical oncologists. OHC continues to bring leading-edge treatment options through its nationally recognized cancer research and clinical trials program. OHC is the first, most experienced, and only certified independent adult cancer practice in the region to offer the revolutionary immunotherapy treatment, CAR-T, for adults, ushering in a new frontier in the fight against cancer. OHC is certified by the American Society of Clinical Oncology in the Quality Oncology Practice Initiative Certification Program and is one of only a select few cancer practices nationally to be accepted to participate in the Oncology Care Model, part of The Center for Medicare & Medicaid Innovation. At its heart, our approach to cancer care is simple — to surround you with everything you need so you can focus on what matters most: beating cancer. For more information about OHC, or a second opinion, call 1-888-649-4800 or visit ohcare.com.
